Prostate Specific Antigen
Serum measurements of prostate specific antigen (PSA) are now being used in the diagnosis and management of prostate cancer. Produced by prostatic epithelium, PSA is a protease involved in liquefaction of the seminal coagulum. Whether this test should be used for routine screening is a matter of controversy; it is currently approved by the US Food and Drug Administration (FDA) only for monitoring after treatment for prostate cancer....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Prostate Specific Antigen
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 880
Article Code: 880b
Date: October 2, 1992
Volume: 34
Pages: 93-94
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 880
Article Code: 880b
Date: October 2, 1992
Volume: 34
Pages: 93-94
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)